Search Results 301-310 of 9836 for 搜索引擎推荐咨询邮箱：lgooxc@hotmail.com
These must be completed in the Recommendation Request section of Recruit. The recommenders will receive an email with a link to upload the letters. After ...
Mayo Clinic cardiologist Mohamad Adnan Alkhouli, M.D., studies aspects of structural heart disease, including valvular interventions, ...
This randomized, placebo-controlled, double-blind, parallel-arm study will evaluate the safety and tolerability of at least two dose levels of intravenous (IV) ...
Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as atezolizumab, may interfere ...
About this study. Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect ...
Contact. Hari Chaliki, M.D.. Program Director. Kaitlyn Robison Education Coordinator Phone: 480-574-2151. Email: robison.kaitlyn@ ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.
About this study. This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an ...
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.